Brain Tumour Support has welcomed the powerful and emotive discussions that took place in Parliament yesterday (Monday 15 June), as the urgent need for greater investment in brain cancer research and treatment was debated. Securing this debate was a notable…
ReadWe are very lucky to have a community of supporters who find different ways to fundraise, and we are delighted to share pictures of the Paul Drew Memorial Vintage Tracker Run, held in Cromhall, South Gloucestershire in aid of Brain…
ReadWhen someone is diagnosed with a brain tumour, they may be overwhelmed by the need to understand a new language. This article aims to provide a shortcut to that new language so that patients, caregivers, colleagues, employers, journalists, policymakers and…
ReadOn Saturday, Penny and her family took to the skies to fundraise for Brain Tumour Support. Penny, her husband Shaun, son and son’s partner took part in their first skydive to raise money for our support services. Penny, who is…
ReadCharles River Laboratories raises over £1,000 for local brain tumour support Earlier this month, our corporate partners, Charles River Laboratories in Keele, took on a Walk for Support to help families living with the impact of a brain tumour diagnosis….
ReadWe know everyone loves a cake and hot drink, and last week, friends Lucy and Caroline raised an incredible £696 through a cake sale at their workplace. With a delicious selection of baked treats up for grabs, the duo brought…
ReadAt Brain Tumour Support, we have been closely following developments around Vorasidenib, a targeted therapy that has shown promise for people living with certain types of low-grade glioma. So we are delighted to share today’s final decision by the National…
ReadAlliance chooses Brain Tumour Support as Charity of the Year Alliance, a leading consumer healthcare business, has chosen Brain Tumour Support as its 2026 Charity of the Year. Just a few months into the partnership, the team had already exceeded…
ReadWe are delighted to share that the Scottish Medicines Consortium (SMC) has approved Vorasidenib (Voranigo) for patients aged 12 and over with IDH-mutant low-grade gliomas, including grade 2 astrocytomas and oligodendrogliomas. This marks an important milestone for patients, families and…
ReadThornbury & District League of Friends have generously donated £1,000 to Brain Tumour Support so we can continue supporting local families impacted by a brain tumour diagnosis. Currently, we are supporting 15 individuals and their families in the Thornbury area….
ReadThis month marks a major milestone in the fight against rare cancers (those affecting fewer than 1 in 2000 people), including brain tumours, as the Rare Cancers Bill has successfully passed its Third Reading in the House of Lords and…
ReadWhen we tell people that brain tumours are the biggest cancer killer of the under 40s, their first reaction is often shock or disbelief. What’s the evidence for this and where do we get our figures from?
Read